Nikolas Herold

17PUBLICATIONS
58CO-AUTHORS
Haematological tumoursTumour immunologyRegenerative medicine (incl. stem cells)Solid tumoursCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 01, 2026
Functionalist Oncology to Model the Contextuality of Dynamics and Treatment in Acute Myeloid Leukaemia.

|Apr 01, 2026
Epigenetic remodeling in sarcoma promotes T-cell infiltration via modulation of the Hippo pathway.

Mireia Cruz De Los Santos, Yi Chen, Amaia González De Zárate

|Sep 27, 2025
Addition of hydroxyurea (hydroxycarbamide) enhances the efficacy of fludarabine/cytarabine-based salvage regimens against acute myeloid leukaemia.

Ingrid Lilienthal, Sijia Tao, Christer Nilsson

|Aug 26, 2025
SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.

Jonas Thier, Sophia Hofmann, Katharina M Kirchhof

|Feb 27, 2024
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma.

Nikolas Herold

|Jan 18, 2024
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.

Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord

Pageof 3

Frequent Collaborators

4 joint publications

Torsten Schaller

4 joint publications

Sean G Rudd

3 joint publications

Ingrid Lilienthal

2 joint publications

Janne Lehtiö